BioPlus Acquisition Corp.
BioPlus Acquisition Corp. (BIOS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIOS · as of Jun 9, 2026
Key Statistics
Explore BioPlus Acquisition Corp. Data
bios stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bios competitorsBIOS
BLNGW
CCAIW
CLRC
CNDB
DPCSStock Performance
Full HistoryAbout BioPlus Acquisition Corp.
BioPlus Acquisition Corp. Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share ex…
what is bioplus acquisition corp. · bios stock overview · bioplus acquisition corp. company profile · who is bioplus acquisition corp. ceo · bios NASDAQ · bioplus acquisition corp. headquarters · bioplus acquisition corp. business segments
About Stock Overview & Key Data
BioPlus Acquisition Corp. (BIOS) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since Jan 28, 2022. As of the latest trading session, BIOS stock price is $10.79, with a market capitalization of $209.1M. The stock has returned +6.56% over the past 12 months and +5.11% year-to-date.
In fiscal year 2022, BioPlus Acquisition Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioPlus Acquisition Corp. (BIOS) stock price is $10.79. The stock is traded on NASDAQ under the ticker symbol BIOS. The 52-week range is $10.12 – $11.68.